切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2024, Vol. 18 ›› Issue (04) : 363 -366. doi: 10.3877/cma.j.issn.1674-3946.2024.04.003

专家论坛

腹腔镜解剖性肝切除的发展
陆朝阳1,(), 金也1, 孙备1   
  1. 1. 150001 哈尔滨,哈尔滨医科大学附属第一医院肝脏外科,肝脾外科教育部重点实验室
  • 收稿日期:2023-11-30 出版日期:2024-08-26
  • 通信作者: 陆朝阳

The development and prospect of laparoscopic anatomic hepatectomy

Zhaoyang Lu1,(), Ye Jin1, Bei Sun1   

  1. 1. Department of Hepatic Surgery, Key Laboratory of Hepatosplenic Surgery, Ministry of Education, the First Affiliated Hospital of Harbin Medical University, Harbin Heilongjiang Province 150001, China
  • Received:2023-11-30 Published:2024-08-26
  • Corresponding author: Zhaoyang Lu
  • Supported by:
    National Natural Science Foundation of China(81972230)
引用本文:

陆朝阳, 金也, 孙备. 腹腔镜解剖性肝切除的发展[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 363-366.

Zhaoyang Lu, Ye Jin, Bei Sun. The development and prospect of laparoscopic anatomic hepatectomy[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(04): 363-366.

解剖性肝切除是指完整切除荷瘤门静脉流域内的肝实质,在其理论与技术操作不断完善、丰富的过程中,对于其实际疗效的质疑与争议从未停歇。先进技术的应用与普及促进肝脏外科迎来新的发展机遇,也为充实并丰富解剖性肝切除理论创造新的契机,有望更好实现肝细胞癌的治疗效果。

Anatomic hepatectomy aims to the complete removal of liver parenchyma within the portal vein. In the process of improvement and enrichment of its theory and technology, there has never been cessation of doubts and controversies. The application and popularization of advanced technology promote new development opportunities in liver surgery, and also create new opportunities to enrich the theory of anatomic hepatectomy, which is expected to better achieve the treatment effect of hepatocellular carcinoma.

[1]
陈琳,陈孝平. 不断推动中国肝癌临床诊治规范化[J/CD].中华普外科手术学杂志(电子版)2022, 16(06), 591-594.
[2]
刘连新,刘光. 中国腹腔镜肝癌手术需要规范几个问题[J/CD].中华普外科手术学杂志(电子版)2022, 16(06), 594-598.
[3]
贾昌俊,戴朝六. 中国腹腔镜肝癌手术式选择与规范化[J/CD].中华普外科手术学杂志(电子版)2022, 16(06), 598-602.
[4]
Couinaud C,Le foie. Etudes Anatomiques et Chirurgicales[M]. Paris: Masson,1957.
[5]
Makuuchi MHasegawa HYamazaki S. Ultrasonically guided subsegmentectomy[J]. Surg Gynecol Obstet1985, 161(4):346-350.
[6]
Shindoh JMakuuchi MMatsuyama Y,et al. Complete removal of the tumor-bearing portal territory decreases local tumor recurrence and improves disease-specific survival of patients with hepatocellular carcinoma[J]. J Hepatol2016,64(3):594-600.
[7]
Hasegawa KKokudo NImamura H,et al.Prognostic impact of anatomic resection for hepatocellular carcinoma[J]. Ann Surg2005, 242(2): 252-259.
[8]
Hokuto DNomi TYasuda S,et al. Does anatomic resection improve the postoperative outcomes of solitary hepatocellular carcinomas located on the liver surface[J]. Surgery2018, 163(2): 285-290.
[9]
Cho JYHan HSChoi Y,et al. Association of Remnant Liver Ischemia With Early Recurrence and Poor Survival After Liver Resection in Patients With Hepatocellular Carcinoma[J]. JAMA Surg2017, 152(4):386-392.
[10]
Moris DTsilimigras DIKostakis ID,et al. Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis[J].Eur J Surg Oncol2018, 44(7): 927-938.
[11]
Moris DTsilimigras DIKostakis ID,et al. Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis[J].Eur J Surg Oncol2018, 44(7): 927-938.
[12]
Li SQHuang TShen SL,et al. Anatomical versus non-ana- tomical liver resection for hepatocellular carcinoma exceeding Milan criteria[J]. Br J Surg2017,104(1):118-127.
[13]
Ju MYopp AC. The utility of anatomical liver resection in hepatocellular carcinoma: associated with improved outcomes or lack of supportive evidence?[J]. Cancers(Basel)2019. 11(10):1441.
[14]
Marubashi SGotoh KAkita H,et al. Anatomical versus non-anatomical resection for hepatocellular carcinoma[J]. Br J Surg2015,102(7):776-784.
[15]
Viganò LProcopio FMimmo A,et al. Oncologic superiority of anatomic resection of hepatocellular carcinoma by ultrasound-guided compression of the portal tributaries compared with nonanatomic resection: an analysis of patients matched for tumor characteristics and liver function[J]. Surgery2018, 164(5):1006-1013.
[16]
Moris DTsilimigras DIKostakis ID,et al. Anatomic versus non-anatomic resection for hepatocellular carcinoma: a systematic review and meta -analysis[J]. Eur J Surg Oncol2018, 44(7):927-938.
[17]
Wu JYSun JXBai YN,et al. Long-term outcomes of anatomic versus nonanatomic resection in hepatocellular carcinoma patients with bile duct tumor thrombus: a propensity score matching analysis[J]. Ann Surg Oncol2021, 28(12):7686-7695.
[18]
Hidaka MEguchi SOkuda K,et al. Impact of anatomical resection for hepatocellular carcinoma with microportal invasion (vp1): a multi-institutional study by the kyushu study group of liver surgery[J]. Ann Surg2020, 271(2):339-346.
[19]
Dip FLoMenzo ESarotto L,et al. Randomized trial of near-infrared incisionless fluorescent cholangiography[J]. Ann Surg2019, 270:992.
[20]
Xiang LXiao LLi J,et al. Safety and feasibility of laparoscopic hepatectomy for hepatocellular carcinoma in the posterosuperior liver segments[J]. World J Surg2015, 39:1202-1209.
[21]
Terasawa MIshizawa TMise Y,et al. Applications of fusion-fluorescence imaging using indocyanine green in laparoscopic hepatectomy[J]. Surg Endosc2017, 31:5111-5118.
[1] 刘连新, 孟凡征. 不断提高腹腔镜解剖性肝切除的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 355-358.
[2] 戴朝六, 赵阳. 腹腔镜解剖性肝切除应该重视的几个问题[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 359-362.
[3] 陈显育, 曾谣, 莫钊鸿, 翟航, 张广权, 钟造茂, 陈署贤. 生物信息学分析CETP基因在肝癌中表达及其对预后和免疫的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 214-219.
[4] 吕垒, 冯啸, 何凯明, 高成立, 杨洲, 贾昌昌, 傅斌生. 组蛋白伴侣VPS72驱动H2AFZ的表达并协同促进肝癌进展[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 220-226.
[5] 宋燕京, 乔江春, 宋京海. 中晚期肝癌TACE联合免疫靶向转化治疗后右半肝切除术一例[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 227-230.
[6] 王礼光, 严庆, 廖珊, 符荣党, 陈焕伟. 微血管侵犯及手术切缘对肝细胞癌患者术后生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 151-157.
[7] 杨建彬, 陈建华, 张文华, 刘建东. 中心静脉压差值对腹腔镜肝细胞癌肝切除术中出血的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 158-162.
[8] 夏辉, 戴斌, 冉君, 王威, 龚昭, 周程. DEP结构域蛋白1B在肝细胞癌中的表达及功能[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 205-213.
[9] 张传海, 周毅, 王一帆, 马金良. 基于"红/黄交界线"胆囊板入路联合ICG荧光导航的腹腔镜解剖性肝切除(附视频)[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 62-67.
[10] 朱迎, 赵征, 许达, 陆录, 殷保兵. 免疫检查点抑制剂治疗肝细胞癌的进展与展望[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 5-10.
[11] 张占国. 靶向免疫治疗时代的肝癌肝切除术再思考[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 11-15.
[12] 孙振, 谭天华, 郑洋洋, 李喆, 宋京海. 基于术前纤维蛋白原与白蛋白比值构建肝癌微血管侵犯的预测模型[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 27-32.
[13] 沈佳佳, 何经雄, 王芳, 江艺, 潘凡, 张小进. ICG荧光引导腹腔镜射频消融在合并严重大结节肝硬化小肝癌患者治疗中的应用[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 68-71.
[14] 张宇, 余灵祥, 杨永平, 赵德希, 刁广浩, 杨木易, 赵亮, 刘佳, 李鹏, 张宁, 任辉. 原发性肝癌Ⅲa期降期后肝切除临床疗效分析[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 78-82.
[15] 严帅, 岳志强, 赵江华, 陈琳, 吴金柱. 初始不可切除肝癌患者靶向免疫联合治疗后手术切除临床疗效[J]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 83-87.
阅读次数
全文


摘要